Icure Pharmaceutical Inc (175250)

Currency in KRW
1,534
+115(+8.10%)
Closed·
175250 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,4011,570
52 wk Range
1,3703,300
Key Statistics
Bid/Ask
1,533.00 / 1,534.00
Prev. Close
1,419
Open
1,401
Day's Range
1,401-1,570
52 wk Range
1,370-3,300
Volume
86.13K
Average Volume (3m)
397.31K
1-Year Change
-29.3088%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
175250 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell

Earnings

Latest Release
Aug 14, 2026
EPS / Forecast
62.00 / --
Revenue / Forecast
37.65B / --
EPS Revisions
Last 90 days

175250 Income Statement

Compare 175250 to Peers and Sector

Metrics to compare
175250
Peers
Sector
Relationship
P/E Ratio
−2.5x−2.4x10.9x
PEG Ratio
0.010.050.03
Price/Book
2.0x2.0x1.5x
Price / LTM Sales
0.5x1.4x0.8x
Upside (Analyst Target)
-7.0%26.0%
Fair Value Upside
Unlock27.4%13.7%Unlock

Icure Pharmaceutical Incorporation, a biopharmaceutical company, researches, develops, and sells pharmaceutical and cosmetic products in South Korea. The company offers functional, nature-derived, derma, and customized cosmetics products. It also offers eye gel, hydro nude gel, lip gel mask, and functional patch products; and sheet, mud, foil, and melting masks. In addition, the company provides body and haircare products, including naturally derived hair and baby line, cleansing tissue, and wet wipes. Further, it offers perfumes, textile perfumes, body mists, and hair and body fragrances. Icure Pharmaceutical Incorporation was founded in 2000 and is based in Seoul, South Korea.

Employees
240

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
110.22K0.29%169.07M
Other Institutional Investors
26.60M71.17%40.80B
Public Companies & Retail Investors
10.66M28.54%16.36B
Total
37.37M100.00%57.33B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Solum Co., Ltd.50.47%18,858,80228,929,402
Sinsin Pharmaceutical Co., Ltd7.76%2,901,3534,450,676

FAQ

What Is the Icure Pharmaceutical (175250) Stock Price Today?

The Icure Pharmaceutical stock price today is 1,534 KRW.

What Stock Exchange Does Icure Pharmaceutical Trade On?

Icure Pharmaceutical is listed and trades on the KOSDAQ.

What Is the Stock Symbol for Icure Pharmaceutical?

The stock symbol for Icure Pharmaceutical is "175250."

What Is the Icure Pharmaceutical Market Cap?

As of today, Icure Pharmaceutical market cap is 57.33B KRW.

What Is Icure Pharmaceutical's Earnings Per Share (TTM)?

The Icure Pharmaceutical EPS (TTM) is -616.26.

From a Technical Analysis Perspective, Is 175250 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Icure Pharmaceutical Stock Split?

Icure Pharmaceutical has split 3 times.

How Many Employees Does Icure Pharmaceutical Have?

Icure Pharmaceutical has 240 employees.

What is the current trading status of Icure Pharmaceutical (175250)?

As of Oct 17, 2026, Icure Pharmaceutical (175250) is trading at a price of 1,534 KRW, with a previous close of 1,419 KRW. The stock has fluctuated within a day range of 1,401 KRW to 1,570 KRW, while its 52-week range spans from 1,370 KRW to 3,300 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.